Drug Approval | March 11, 2023
USFDA completes inspection of Lupin’s Vizag facility
The inspection concluded with no observations
The inspection concluded with no observations
New GMP facility for clinical and small-scale commercial pharmaceutical lipids
Based on this inspection and the USFDA VAI classification, this facility is in compliance with regard to current good manufacturing practices (cGMP)
Resomer used in commercial 3D-printed implants for both soft and hard tissue applications
This order is subject to initial advance payment as per the agreed terms of the contract and this order will be executed within 6 to 8 months.
The marketing authorisations for three generic drugs signifying advances in cancer treatment will considerably benefit thousands of patients by improving access, ensuring affordability
The new sterile filling line meets cGMP aseptic filling regulatory requirements
Cipla has received 8 inspectional observations in Form 483
The company has launched its new range of 25 allopathy ophthalmic products including GUERIMOD, GUERIPRED, BIMATO MST etc. for curing various diseases related to eyes
This registration enables companies to register the products (Orodispersible films and Transdermal systems) in UAE for commercialization
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
